Ghrelin
From PeptidePlaza, the free peptide reference · Entry #1046 · Metabolic · Sources fetched 2026-09-10 · Editorial standards
Ghrelin (also known as Gastric MLTRP, Ppghrelin, Ghrelin Precursor, Precursor, Ghrelin) is a metabolic research peptide. Ghrelin is a peptide hormone that acts as a ligand for the growth hormone secretagogue receptor (GHSR). It is involved in regulating appetite, metabolism, and growth hormone release.
Ghrelin is a 28-amino acid peptide hormone primarily produced in the stomach, functioning as an endogenous ligand for the growth hormone secretagogue receptor (GHSR). Its primary role involves stimulating growth hormone release from the pituitary gland and regulating energy homeostasis, including appetite stimulation and fat storage. Ghrelin is currently an investigational compound, with extensive research exploring its multifaceted roles. Studies have investigated its relationship to blood glucose, its involvement in gastrointestinal diseases, and its influence on reward and motivation pathways. The literature also focuses on its participation in various feedback systems within the body.
1 Chemical and physical properties
| CAS number | 304853-26-7 |
|---|---|
| Molar mass | 3370.9 g/mol |
| Purity (typical) | Not independently verified |
| Storage | −20 °C, lyophilised powder, desiccated |
| Solubility | Sterile water / bacteriostatic water |
2 Research studies (8)
- Biochemistry, Ghrelin
(2026) - Ghrelin's Relationship to Blood Glucose
Endocrinology (2019) · Review - Ghrelin in gastrointestinal disease
Molecular and cellular endocrinology (2011) · Review - Ghrelin, reward and motivation
Endocrine development (2013) · Review - Ghrelin and feedback systems
Vitamins and hormones (2008) · Review - Physiological roles of ghrelin on obesity
Obesity research & clinical practice (2014) · Review - Ghrelin--not just another stomach hormone
Regulatory peptides (2002) · Review - Ghrelin and the Control of Energy Balance in Females
Frontiers in endocrinology (2022) · Review
3 Safety and risk profile
3.1 Regulatory status
Ghrelin is currently classified as Investigational. It has no approved human indication in the United States; availability elsewhere does not imply demonstrated safety or efficacy.
4 Frequently asked questions
- What is Ghrelin?
- Ghrelin is a 28-amino acid peptide hormone predominantly synthesized in the stomach. It functions as an endogenous ligand for the growth hormone secretagogue receptor (GHSR), playing a key role in several physiological processes.
- How does Ghrelin work?
- Ghrelin primarily works by binding to and activating the growth hormone secretagogue receptor (GHSR). This activation leads to the stimulation of growth hormone release from the pituitary gland and influences metabolic processes, including appetite regulation.
- What is Ghrelin studied for?
- Ghrelin is studied for its roles in regulating appetite, metabolism, and growth hormone release. Research also explores its relationship to blood glucose, its involvement in gastrointestinal diseases, and its impact on reward and motivation.
- Is Ghrelin FDA approved?
- Ghrelin is currently an investigational compound and is not FDA approved for any therapeutic use. Research is ongoing to understand its potential applications.
5 References
- Ghrelin — compound summary PubChem. View source
- Ghrelin — molecule record ChEMBL. View source
- Ghrelin — published literature (13,056 records) PubMed. View source
Related compounds
Entries that share a target, a mechanism, or a research area with Ghrelin.
Also metabolic
Gastrin is an endogenous human peptide that stimulates the stomach mucosa to produce and secrete hydrochloric acid and the pancreas to secrete digestive enzymes.
Also metabolic
Seractide Acetate is a synthetic peptide that acts as a melanocortin receptor 2 agonist.
Also metabolic
Parathyroid Hormone is an 84-residue peptide that acts as a parathyroid hormone receptor agonist. It is FDA approved and marketed as Bestmade Natural Products BM67.
Also metabolic
Octreotide is a somatostatin analog indicated for reducing growth hormone and IGF-1 levels in acromegaly, and for managing severe diarrhea and flushing associated with metastatic carcinoid tumors and VIPomas.
Also metabolic
The GLP-1 that proved the class. A C16 palmitoyl chain gave native GLP-1 a 13-hour half-life instead of two minutes — and produced the first cardiovascular outcome data for the family.
Also metabolic
A long-acting GLP-1 analog distinguished by its C18 fatty diacid chain, enabling albumin binding and a half-life of ~7 days. One of the most clinically studied peptides in modern metabolic research.